tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IT:1BMY Stock Latest News

Private Markets: Anthropic projects $70B in revenue in 2028
The FlyPrivate Markets: Anthropic projects $70B in revenue in 2028
2d ago
S
BMY
Bristol Myers reaches $239M settlement over Otezla, Zeposia, Reuters reports
PremiumThe Fly
Bristol Myers reaches $239M settlement over Otezla, Zeposia, Reuters reports
3d ago
BMY
Balanced Outlook on Bristol-Myers Squibb: Strong Q3 Performance Amid ADEPT-2 Trial Concerns
PremiumRatings
Balanced Outlook on Bristol-Myers Squibb: Strong Q3 Performance Amid ADEPT-2 Trial Concerns
6d ago
BMY
Bristol Myers price target raised to $52 from $50 at BofA
PremiumThe Fly
Bristol Myers price target raised to $52 from $50 at BofA
6d ago
BMY
Bristol-Myers Squibb Launches $7 Billion Tender Offer
PremiumCompany Announcements
Bristol-Myers Squibb Launches $7 Billion Tender Offer
7d ago
8K
BMY
Bristol-Myers Squibb’s Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsBristol-Myers Squibb’s Earnings Call Highlights Growth and Challenges
9d ago
BMY
Bristol Myers files automatic mixed securities shelf
Premium
The Fly
Bristol Myers files automatic mixed securities shelf
9d ago
BMY
Bristol-Myers Squibb: Balancing Strong Product Performance with Market Challenges and Patent Pressures
Premium
Ratings
Bristol-Myers Squibb: Balancing Strong Product Performance with Market Challenges and Patent Pressures
9d ago
BMY
Bristol Myers Squibb Reports Strong Q3 2025 Results
PremiumCompany Announcements
Bristol Myers Squibb Reports Strong Q3 2025 Results
10d ago
BMY
Metsera held talks with Bristol Myers before Novo Nordisk, Pfizer, WSJ reports
PremiumThe Fly
Metsera held talks with Bristol Myers before Novo Nordisk, Pfizer, WSJ reports
10d ago
BMY
NVO
Unusually active option classes on open October 30th
PremiumThe Fly
Unusually active option classes on open October 30th
10d ago
BP
MO
Balanced Outlook on Bristol-Myers Squibb: Hold Rating Amid Strong Immuno-Oncology Growth and Pipeline Uncertainties
PremiumRatings
Balanced Outlook on Bristol-Myers Squibb: Hold Rating Amid Strong Immuno-Oncology Growth and Pipeline Uncertainties
10d ago
BMY
Bristol-Myers Squibb Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsBristol-Myers Squibb Reports Q3 2025 Financial Results
11d ago
8K
BMY
Bristol Myers reports Q3 adjusted EPS $1.63, consensus $1.52
Premium
The Fly
Bristol Myers reports Q3 adjusted EPS $1.63, consensus $1.52
11d ago
BMY
Bristol Myers now sees FY25 adjusted EPS $6.40-$6.60, consensus $6.36
Premium
The Fly
Bristol Myers now sees FY25 adjusted EPS $6.40-$6.60, consensus $6.36
11d ago
BMY
FDA moves to accelerate biosimilar development, lower drug costs
PremiumThe Fly
FDA moves to accelerate biosimilar development, lower drug costs
11d ago
AZN
BMY
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
11d ago
K
CI
BMY Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BMY Upcoming Earnings Report: What to Expect?
13d ago
BMY
Hold Rating for Bristol-Myers Squibb Amid Fair Valuation and Mixed Growth Prospects
PremiumRatings
Hold Rating for Bristol-Myers Squibb Amid Fair Valuation and Mixed Growth Prospects
13d ago
BMY
Bristol Myers’ Sotyktu shows efficacy in arthritis and SLE
PremiumThe FlyBristol Myers’ Sotyktu shows efficacy in arthritis and SLE
14d ago
BMY
Bristol Myers announces updated data from Phase 1 study of CD19
Premium
The Fly
Bristol Myers announces updated data from Phase 1 study of CD19
14d ago
BMY
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
17d ago
BMY
NVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >